Fate Therapeutics (FATE) stock forecast for 2025. Forecast tables and graphs.







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Fate Therapeutics (FATE) stock forecast for 2025

Updated: May 24, 2024 (17:36)

Sector: Healthcare

The share price of Fate Therapeutics, Inc. (FATE) now

What analysts predict: $6.8
52-week High/Low: $8.83 / $1.63

50/200 Day Moving Average: $5.35 / $4.051

This figure corresponds to the Average Price over the previous 50/200 days. For Fate Therapeutics stocks, the 50-day moving average is the resistance level today.

For Fate Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Fate Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Fate Therapeutics stock price in 2025. How much will one Fate Therapeutics share be worth in 2025? Is it worth taking profit / loss on FATE stock now or waiting? What are analysts' forecasts for Fate Therapeutics stock?

We forecast Fate Therapeutics stock performance using neural networks based on historical data on FATE stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Fate Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Fate Therapeutics analysts is $6.8. Today 200 Day Moving Average is the support level (4.051 $). 50 Day Moving Average is the resistance level (5.35 $).




Historical and forecast chart of Fate Therapeutics, Inc. stock

The chart below shows the historical price of Fate Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the FATE stock price can be found in the table below.


Fate Therapeutics, Inc. provides biopharmaceutical services. The company researches and develops therapies for the restoration and regeneration of body tissues using stem cells. The company operates in the USA.

Official website of the company

Fate Therapeutics (FATE) Forecast for 2025

Month Target Pes. Opt. Vol., %
Jan 4.24 4.11 4.63 11.41 %
Feb 4.21 3.94 4.40 10.44 %
Mar 3.69 3.28 4.00 18.06 %
Apr 3.45 3.34 3.74 10.59 %
May 3.36 3.10 3.67 15.51 %
Jun 3.33 3.06 3.45 11.23 %
Jul 3.60 3.21 3.74 14.01 %
Aug 3.94 3.50 4.36 19.74 %
Sep 3.80 3.58 4.13 13.29 %
Oct 3.67 3.27 3.90 16.33 %
Nov 4.13 4.01 4.44 9.63 %
Dec 4.27 4.14 4.70 11.83 %

Fate Therapeutics information and performance

Fate Therapeutics Address

3535 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, US

Market Capitalization: 415 486 000 $

Market capitalization of the Fate Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of FATE shares in the company outstanding by the market price of one share.

EBITDA: -181 175 008 $

EBITDA of Fate Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.92

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.967
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 7.02

Enterprise Value (EV) /Revenue

EV To EBITDA: -2.59

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 113832000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Fate Therapeutics price target for 2025 by month


Target values for the price of one Fate Therapeutics share for Jan 2025.

The weighted average target price per Fate Therapeutics share in Jan 2025 is: 4.24.
In Jan, the Positive dynamics for Fate Therapeutics, Inc. shares will prevail with possible monthly volatility of 11.406% volatility is expected.
Pessimistic target level: 4.11
Optimistic target level: 4.63

Target values for the price of one Fate Therapeutics share for Feb 2025.

The weighted average target price per Fate Therapeutics share in Feb 2025 is: 4.21.
In Feb, the Negative dynamics for Fate Therapeutics, Inc. shares will prevail with possible monthly volatility of 10.438% volatility is expected.
Pessimistic target level: 3.94
Optimistic target level: 4.40

Target values for the price of one Fate Therapeutics share for Mar 2025.

The weighted average target price per Fate Therapeutics share in Mar 2025 is: 3.69.
In Mar, the Negative dynamics for Fate Therapeutics, Inc. shares will prevail with possible monthly volatility of 18.058% volatility is expected.
Pessimistic target level: 3.28
Optimistic target level: 4.00

Target values for the price of one Fate Therapeutics share for Apr 2025.

The weighted average target price per Fate Therapeutics share in Apr 2025 is: 3.45.
In Apr, the Negative dynamics for Fate Therapeutics, Inc. shares will prevail with possible monthly volatility of 10.590% volatility is expected.
Pessimistic target level: 3.34
Optimistic target level: 3.74

Target values for the price of one Fate Therapeutics share for May 2025.

The weighted average target price per Fate Therapeutics share in May 2025 is: 3.36.
In May, the Negative dynamics for Fate Therapeutics, Inc. shares will prevail with possible monthly volatility of 15.507% volatility is expected.
Pessimistic target level: 3.10
Optimistic target level: 3.67

Target values for the price of one Fate Therapeutics share for Jun 2025.

The weighted average target price per Fate Therapeutics share in Jun 2025 is: 3.33.
In Jun, the Negative dynamics for Fate Therapeutics, Inc. shares will prevail with possible monthly volatility of 11.227% volatility is expected.
Pessimistic target level: 3.06
Optimistic target level: 3.45

Target values for the price of one Fate Therapeutics share for Jul 2025.

The weighted average target price per Fate Therapeutics share in Jul 2025 is: 3.60.
In Jul, the Positive dynamics for Fate Therapeutics, Inc. shares will prevail with possible monthly volatility of 14.011% volatility is expected.
Pessimistic target level: 3.21
Optimistic target level: 3.74

Target values for the price of one Fate Therapeutics share for Aug 2025.

The weighted average target price per Fate Therapeutics share in Aug 2025 is: 3.94.
In Aug, the Positive dynamics for Fate Therapeutics, Inc. shares will prevail with possible monthly volatility of 19.740% volatility is expected.
Pessimistic target level: 3.50
Optimistic target level: 4.36

Target values for the price of one Fate Therapeutics share for Sep 2025.

The weighted average target price per Fate Therapeutics share in Sep 2025 is: 3.80.
In Sep, the Negative dynamics for Fate Therapeutics, Inc. shares will prevail with possible monthly volatility of 13.286% volatility is expected.
Pessimistic target level: 3.58
Optimistic target level: 4.13

Target values for the price of one Fate Therapeutics share for Oct 2025.

The weighted average target price per Fate Therapeutics share in Oct 2025 is: 3.67.
In Oct, the Negative dynamics for Fate Therapeutics, Inc. shares will prevail with possible monthly volatility of 16.331% volatility is expected.
Pessimistic target level: 3.27
Optimistic target level: 3.90

Target values for the price of one Fate Therapeutics share for Nov 2025.

The weighted average target price per Fate Therapeutics share in Nov 2025 is: 4.13.
In Nov, the Positive dynamics for Fate Therapeutics, Inc. shares will prevail with possible monthly volatility of 9.632% volatility is expected.
Pessimistic target level: 4.01
Optimistic target level: 4.44

Target values for the price of one Fate Therapeutics share for Dec 2025.

The weighted average target price per Fate Therapeutics share in Dec 2025 is: 4.27.
In Dec, the Positive dynamics for Fate Therapeutics, Inc. shares will prevail with possible monthly volatility of 11.828% volatility is expected.
Pessimistic target level: 4.14
Optimistic target level: 4.70



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.